Disease-modifying drugs for multiple sclerosis and JC virus expression

Journal of NeuroVirology

Volumn 18, Issue 5, 2012, Pages 411-415

  Miller, Craig S ^c   Houff, Sidney A ^a   Hopper, Jason ^b   Danaher, Robert J ^c   Gurwell, Julie A ^a   Lin, Yushun ^b   Vega, Nubia ^a   Berger, Joseph R ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY COLLEGE OF DENTISTRY   (United States)

Author keywords

Glatiramir acetate; Interferon ; JC virus; Multiple sclerosis; Progressive multifocal leukoencephalopathy

Indexed keywords

ALEMTUZUMAB; BETA1A INTERFERON; GLATIRAMER; INTERFERON BETA SERINE; MITOXANTRONE; NATALIZUMAB; VIRUS DNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COPY NUMBER VARIATION; DISEASE DURATION; FEMALE; HUMAN; HUMAN CELL; JC VIRUS; MALE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; URINALYSIS; VIRUS EXPRESSION; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; CELL MIGRATION INHIBITION; CROSS-SECTIONAL STUDIES; DNA, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INTERFERON-BETA; JC VIRUS; LEUKOCYTES, MONONUCLEAR; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PEPTIDES; POLYMERASE CHAIN REACTION; VIRAL LOAD;

EID: 84867292437     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-012-0107-0     Document Type: Article

References (19)

1. Alvarez-Lafuente R, Garcia-Montojo M et al (2007) Interferon-beta treatment and active replication of the JC virus in relapsingremitting multiple sclerosis patients. Eur J Neurol 14(2):233-236
2. Berger J, Pall L et al (1992) A pilot study of recombinant alpha 2a interferon in the treatment of AIDS-related progressive multifocal leukoencephalopathy (abstract). Neurology 42(Suppl 3):257
3. Berger JR, Miller CS et al (2006) JC virus detection in bodily fluids: clues to transmission. Clin Infect Dis 43(1):e9-e12
4. BiogenIdec (2011) PML incidence in patients receiving TYSABRI. https://medinfo.biogenidec.com/medinfo/secure/pmlresource.do? resource0TYSABRIPMLSafetyUpdate. Accessed 26 Nov. 2011
5. Biron CA (1999) Initial and innate responses to viral infections-pattern setting in immunity or disease. Curr Opin Microbiol 2(4):374-381
6. Chang H, Wang M et al (2002) High incidence of JC viruria in JC-seropositive older individuals. J Neurovirol 8(5):447-451
7. Co JK, Verma S et al (2007) Interferon-alpha and -beta restrict polyomavirus JC replication in primary human fetal glial cells: implications for progressive multifocal leukoencephalopathy therapy. J Infect Dis 196(5):712-718
8. Delbue S, Guerini FR et al (2007) JC virus viremia in interferon-betatreated and untreated Italian multiple sclerosis patients and healthy controls. J Neurovirol 13(1):73-77
9. Egli A, Infanti L et al (2009) Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 199(6):837-846
10. Gorelik L, Lerner M et al (2010) Anti-JC virus antibodies: implications for PML risk stratification. Ann Neurol 68(3):295-303
11. Kawai T, Akira S (2006) Innate immune recognition of viral infection. Nat Immunol 7(2):131-137
12. Kleinschmidt-DeMasters BK, Tyler KL (2005) Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 353(4):369-374
13. Langer-Gould A, Atlas SW et al (2005) Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 353(4):375-381
14. MacKenzie J, Wilson KS et al (2003) Association between simian virus 40 DNA and lymphoma in the United Kingdom. J Natl Cancer Inst 95(13):1001-1003
15. Nath A, Venkataramana A et al (2006) Progression of progressive multifocal leukoencephalopathy despite treatment with beta-interferon. Neurology 66(1):149-150
16. Pagani E, Delbue S et al (2003) Molecular analysis of JC virus genotypes circulating among the Italian healthy population. J Neurovirol 9(5):559-566
17. Polo C, Perez JL et al (2004) Prevalence and patterns of polyomavirus urinary excretion in immunocompetent adults and children. Clin Microbiol Infect 10(7):640-644
18. Verma S, Ziegler K et al (2006) JC virus induces altered patterns of cellular gene expression: interferon-inducible genes as major transcriptional targets. Virology 345(2):457-467
19. Yousry TA, Major EO et al (2006) Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 354(9):924-933